The mark consists of the wording "ZEPBOUND" in stylized font, "ZEP" in blue and "BOUND" in green with a cutout of an arrowhead on the left side of the letter "B" and three green arrowheads after the word.
Mark For: ZEPBOUND™ trademark registration is intended to cover the categories of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases. [all]
>The color(s) blue and green is/are claimed as a feature of the mark. The mark consists of the wording "ZEPBOUND" in stylized font, "ZEP" in blue and "BOUND" in green with a cutout of an arrowhead on the left side of the letter "B" and three green arrowheads after the word.
Status
2023-11-09 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type
TRADEMARK
Standard Character Claim
No
Register
PRINCIPAL
Current Location
INTENT TO USE SECTION 2023-05-16
Basis
1(b)
Class Status
ACTIVE
Primary US Classes
005:
Adhesives
006:
Chemicals and Chemical Compositions
018:
Medicines and Pharmaceutical Preparations
044:
Dental, Medical and Surgical Appliances
046:
Foods and Ingredients of Foods
051:
Cosmetics and Toilet Preparations
052:
Detergents and Soaps
Primary International Class
005 - Primary Class
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Bruce W. Longbottom
Timeline
2022-08-02
Application Filed
2022-08-05
Location: NEW APPLICATION PROCESSING
2022-08-05
Status: Live/Pending
2022-08-05
Transaction Date
2023-03-21
Published
2023-05-16
Location: INTENT TO USE SECTION
2023-10-17
Status: A first request for extension of time to file a Statement of Use has been granted.
BRUCE W. LONGBOTTOM ELI LILLY AND COMPANY LILLY CORPORATE CENTER INDIANAPOLIS, IN 46285
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
Type Code
Type
DM0000
The mark consists of the wording zepbound in stylized font, "zep" in blue and "bound" in green with an imbedded arrow between "p" and "b" and three rounded arrows after the word.
Trademark Filing History
Description
Date
Proceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2023-10-19
SOU TEAS EXTENSION RECEIVED
2023-10-17
SOU EXTENSION 1 GRANTED
2023-10-17
98765
SOU EXTENSION 1 FILED
2023-10-17
98765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2023-05-16
PUBLISHED FOR OPPOSITION
2023-03-21
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
www.lilly.com
OneLook
Acronym Finder
Eli Lilly and Company
Application
| 